Literature DB >> 12787669

Catalytic mechanism of DNA-(cytosine-C5)-methyltransferases revisited: covalent intermediate formation is not essential for methyl group transfer by the murine Dnmt3a enzyme.

Sabine Reither1, Fuyang Li, Humaira Gowher, Albert Jeltsch.   

Abstract

Co-transfections of reporter plasmids and plasmids encoding the catalytic domain of the murine Dnmt3a DNA methyltransferase lead to inhibition of reporter gene expression. As Dnmt3a mutants with C-->A and E-->A exchanges in the conserved PCQ and ENV motifs in the catalytic center of the enzyme also cause repression, we checked for their catalytic activity in vitro. Surprisingly, the activity of the cysteine variant and of the corresponding full-length Dnmt3a variant is only two to sixfold reduced with respect to wild-type Dnmt3a. In contrast, enzyme variants carrying E-->A, E-->D or E-->Q exchanges of the ENV glutamate are catalytically almost inactive, demonstrating that this residue has a central function in catalysis. Since the glutamic acid residue contacts the flipped base, its main function could be to hold the target base at a position that supports methyl group transfer. Whereas wild-type Dnmt3a and the ENV variants form covalent complexes with 5-fluorocytidine modified DNA, the PCN variant does not. Therefore, covalent complex formation is not essential in the reaction mechanism of Dnmt3a. We propose that correct positioning of the flipped base and the cofactor and binding to the transition state of methyl group transfer are the most important roles of the Dnmt3a enzyme in the catalytic cycle of methyl group transfer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787669     DOI: 10.1016/s0022-2836(03)00509-6

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  19 in total

1.  Mapping of protein-protein interaction sites by the 'absence of interference' approach.

Authors:  Arunkumar Dhayalan; Tomasz P Jurkowski; Heike Laser; Richard Reinhardt; Da Jia; Xiaodong Cheng; Albert Jeltsch
Journal:  J Mol Biol       Date:  2007-12-23       Impact factor: 5.469

Review 2.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

3.  Cooperative DNA binding and protein/DNA fiber formation increases the activity of the Dnmt3a DNA methyltransferase.

Authors:  Max Emperle; Arumugam Rajavelu; Richard Reinhardt; Renata Z Jurkowska; Albert Jeltsch
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

Review 4.  Molecular and enzymatic profiles of mammalian DNA methyltransferases: structures and targets for drugs.

Authors:  F Xu; C Mao; Y Ding; C Rui; L Wu; A Shi; H Zhang; L Zhang; Z Xu
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 5.  Repeat-Induced Point Mutation and Other Genome Defense Mechanisms in Fungi.

Authors:  Eugene Gladyshev
Journal:  Microbiol Spectr       Date:  2017-07

6.  Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase-like catalytic mechanism.

Authors:  Tomasz P Jurkowski; Madeleine Meusburger; Sameer Phalke; Mark Helm; Wolfgang Nellen; Gunter Reuter; Albert Jeltsch
Journal:  RNA       Date:  2008-06-20       Impact factor: 4.942

Review 7.  Mammalian DNA methyltransferases: a structural perspective.

Authors:  Xiaodong Cheng; Robert M Blumenthal
Journal:  Structure       Date:  2008-03       Impact factor: 5.006

8.  Expression level and immunolocalization of de novo methyltransferase 3 protein (TuDNMT3) in adult females and males of the two-spotted spider mite, Tetranychus urticae.

Authors:  Si-Xia Yang; Chao Guo; Yan-Kai Zhang; Jing-Tao Sun; Xiao-Yue Hong
Journal:  Exp Appl Acarol       Date:  2015-08-06       Impact factor: 2.132

9.  5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.

Authors:  Kalpana Ghoshal; Jharna Datta; Sarmila Majumder; Shoumei Bai; Huban Kutay; Tasneem Motiwala; Samson T Jacob
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

10.  Inhibition of cancer cell proliferation by 5-fluoro-2'-deoxycytidine, a DNA methylation inhibitor, through activation of DNA damage response pathway.

Authors:  Quanyi Zhao; Jiadong Fan; Wei Hong; Lianyun Li; Min Wu
Journal:  Springerplus       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.